Improvement in the delivery system of bone morphogenetic protein-2: a new approach to promote bone formation

Biomedical Materials
Quan ZhangFei-long Deng

Abstract

Much research has been focused on developing bone morphogenetic protein-2(BMP-2) delivery systems to enhance bone formation in bone defect repair and bone tissue engineering. However, many of these current systems have several drawbacks associated with low loading efficiencies and reduced biological activities after release. Collagen scaffolds can be used as in delivery systems because of their biocompatibility. However, growth factors have naturally low affinity to collagen, which is disadvantageous for maintaining a sufficient growth factor concentration at the delivery sites. To enhance BMP-2 binding to collagen scaffolds, we chose a porous collagen scaffold that was chemically modified using Traut's reagent. The modified collagen scaffold allows cross-linking of the collagen fibers and is able to immobilize more BMP-2 after treatment with Sulfo-SMCC. We demonstrated that cross-linking led to a slower release rate of BMP-2, but did not reduce its biological activity. Moreover, more ectopic bone formation was induced by subcutaneous implants of cross-linked collagen treated with BMP-2. We concluded that collagen scaffolds chemically conjugated with BMP-2 using Traut's reagent and Sulfo-SMCC was an effective delivery system fo...Continue Reading

References

Mar 14, 2002·Biochemical and Biophysical Research Communications·Felicity R A J Rose, Richard O C Oreffo
Apr 9, 2002·Clinical Orthopaedics and Related Research·S Tim Yoon, Scott D Boden
Apr 12, 2002·Journal of Biomedical Materials Research·Wan-Ju LiFrank K Ko
Oct 1, 2003·Journal of Biomedical Materials Research. Part a·Manuela E GomesAntonios G Mikos
Jul 28, 2004·Biomaterials·F J O'BrienL J Gibson
Oct 13, 2004·Journal of Biomedical Materials Research. Part a·Vassilis KarageorgiouDavid Kaplan
May 25, 2005·Biotechnology and Applied Biochemistry·Yoon Jeong ParkChong Pyoung Chung
Jan 20, 2007·Journal of Biomedical Materials Research. Part a·Bina RaiRobert E Guldberg
Oct 17, 2007·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Brian StevensKytai Truong Nguyen
Jul 8, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Yannan ZhaoJianwu Dai
Mar 20, 2010·Journal of Materials Science. Materials in Medicine·Guangping XieJie Wei
May 27, 2010·The Journal of Biological Chemistry·Liza J Raggatt, Nicola C Partridge
Aug 13, 2010·Acta Diabetologica·N NapoliP Pozzilli
Aug 27, 2010·Journal of Materials Science. Materials in Medicine·Pinar YilgorVasif Hasirci
Jan 5, 2011·Frontiers in Bioscience (Scholar Edition)·Wook-Young Baek, Jung-Eun Kim
Jan 14, 2011·Biomaterials·Chunying ShiJianwu Dai
Feb 4, 2011·Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine·A S BrydoneS Maclaine
Feb 4, 2011·Proceedings of the Institution of Mechanical Engineers. Part H, Journal of Engineering in Medicine·P Jayakumar, L Di Silvio
May 3, 2011·Tissue Engineering. Part a·Hee Seok YangByung-Soo Kim
Aug 24, 2011·Brazilian Journal of Otorhinolaryngology·Adalberto Novaes SilvaWilma Terezinha Anselmo Lima
Aug 31, 2011·Bosnian Journal of Basic Medical Sciences·Weimin ZhuYanjun Zeng

❮ Previous
Next ❯

Citations

Nov 16, 2012·Tissue Engineering. Part B, Reviews·Silviya P ZustiakJennie B Leach
Dec 20, 2013·Regenerative Medicine·Josephine FangBo Han
Dec 3, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Salwa SulimanKamal Mustafa
Jan 6, 2016·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Vishal Agrawal, Mukty Sinha
Jan 3, 2013·Journal of Biomedical Materials Research. Part a·Stefan ZwingenbergerMaik Stiehler
Dec 22, 2016·Expert Opinion on Therapeutic Targets·Christophe GuignabertMarc Humbert
Feb 12, 2020·Journal of Biomedical Materials Research. Part a·Sahitya InjamuriYue-Wern Huang
Dec 14, 2018·Experimental and Therapeutic Medicine·Shiqiang RuanWenliang Huang
Jul 28, 2014·Journal of Materials Chemistry. B, Materials for Biology and Medicine·Ziqiang KongHuiming Wang
Mar 10, 2017·Journal of Biomaterials Science. Polymer Edition·Yiming LiFeilong Deng
Aug 30, 2017·International Journal of Biological Macromolecules·Shalini V GohilLakshmi S Nair
Jan 25, 2019·ACS Applied Materials & Interfaces·Lauren M CrossAkhilesh K Gaharwar
Jul 25, 2018·Chemical Reviews·Christopher D SpicerMolly M Stevens

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.